SynBioBeta Speaker
Ekaterine Kortkhonjia
Johnson and Johnson
Sr. Director, Transactions
Eka Kortkhonjia, Ph.D., M.S., is a Senior Director of Transactions at Johnson & Johnson, where she leads strategic partnering efforts aimed at advancing transformative innovation across the company’s priority therapeutic areas. In her role, she is responsible for evaluating external scientific opportunities, overseeing due diligence, and structuring strategic transactions that support the company’s long term R&D and portfolio objectives.Eka also plays a key role in shaping the innovation ecosystem surrounding Johnson & Johnson. She supports the Johnson & Johnson Innovation – JJDC venture fund, working closely with early stage companies to accelerate breakthrough science. In addition, she collaborates with the global JLABS incubator network, helping nurture emerging biotech and technology platforms by providing strategic insights and fostering connections that enable growth.Prior to joining Johnson & Johnson, Eka spent more than 13 years at Genentech/Roche in roles of increasing responsibility across Pharma Partnering, Biomarker Development, and Investor Relations. Her experience spans end to end partnering strategy, biomarker and translational program leadership, and communication of scientific and business priorities to investors and external stakeholders. Throughout her career, Eka has built a strong track record of integrating science, strategy, and cross functional collaboration to support innovation from discovery to development.Before transitioning into industry leadership roles, Eka completed postdoctoral training at both the University of California, Los Angeles (UCLA) and Genentech. During this time, she conducted research at the intersection of biophysics, structural biology, and translational science, contributing to a deeper understanding of complex biological systems. Eka holds a Ph.D. in Chemistry and Chemical Biology and an M.S. in Biophysics.
All Categories
